AI assistant
BIO-TECHNE Corp — Director's Dealing 2019
Aug 21, 2019
30718_dirs_2019-08-21_875778ac-b24c-40ee-aa35-90671858dea9.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BIO-TECHNE Corp (TECH)
CIK: 0000842023
Period of Report: 2019-08-19
Reporting Person: Furlow Brenda S. (SVP - General Counsel)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2019-08-19 | Common Stock | M | 1759 | — | Acquired | 3948 | Direct |
| 2019-08-19 | Common Stock | F | 745 | $197.57 | Disposed | 3203 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2019-08-19 | Restricted Stock Units | $ | M | 1759 | Disposed | Common Stock (1759) | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Options (Right to Buy) | $94.35 | 2021-08-12 | Common Stock (9600) | 9600 | Direct |
| Stock Options (Right to Buy) | $108.49 | 2022-08-07 | Common Stock (10000) | 10000 | Direct |
| Stock Options (Right to Buy) | $108.49 | 2022-08-07 | Common Stock (5995) | 5995 | Direct |
| Stock Options (Right to Buy) | $106.59 | 2023-08-18 | Common Stock (10857) | 10857 | Direct |
| Stock Options (Right to Buy) | $106.59 | 2023-08-18 | Common Stock (14476) | 14476 | Direct |
| Restricted Stock Units | $ | Common Stock (1724) | 1724 | Direct | |
| Stock Options (Right to Buy) | $125.05 | 2024-08-09 | Common Stock (9503) | 9503 | Direct |
| Stock Options (Right to Buy) | $125.05 | 2024-08-09 | Common Stock (12670) | 12670 | Direct |
| Restricted Stock Units | $ | Common Stock (1374) | 1374 | Direct | |
| Stock Options (Right to Buy) | $177.32 | 2025-08-08 | Common Stock (7339) | 7339 | Direct |
| Stock Options (Right to Buy) | $177.32 | 2025-08-08 | Common Stock (9786) | 9786 | Direct |
| Restricted Stock Units | $ | Common Stock (1969) | 1969 | Direct | |
| Stock Options (Right to Buy) | $190.41 | 2026-08-07 | Common Stock (9968) | 9968 | Direct |
| Stock Options (Right to Buy) | $190.41 | 2026-08-07 | Common Stock (13290) | 13290 | Direct |
Footnotes
F1: Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock.
F2: Fully exercisable.
F3: On 8/19/2019, the Board of Directors certified vesting of 1,759 performance RSUs.
F4: Options to purchase 3,619 shares vest on each of 8/18/2017, 8/18/2018, 8/18/2019 and 8/18/2020.
F5: Vests in full or in part on 8/9/2020 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
F6: Options to purchase 3,167 shares vest on each of 8/9/2018 and 8/9/2019 and options to purchase 3,168 shares vest on each of 8/9/2020 and 8/9/2021.
F7: Vests in full or in part on 8/8/2021 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
F8: Options to purchase 2,447 shares vest on each of 8/8/2019 and 8/8/2020 and options to purchase 2,446 shares vest on each of 8/8/2021 and 8/8/2022.
F9: Vests in full or in part on 8/7/2022 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
F10: Options to purchase 3,323 shares vest on each of 8/7/2020 and 8/7/2021 and options to purchase 3,322 shares vest on each of 8/7/2022 and 8/7/2023.